Liabilities / Assets
57th percentile
Higher debt load relative to assets than 57% of similar nonprofits.
Peptide Therapeutics Foundation
990EZ • Fiscal year 2021 • EIN 26-3728931
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
59th percentile
Higher debt load relative to revenue than 59% of similar nonprofits.
Net Margin
9th percentile
Higher net margin than 9% of similar nonprofits.
Top Officer Pay
77th percentile
Higher top officer pay than 77% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
21st percentile
Faster asset growth than 21% of similar nonprofits.
Revenue Growth
76th percentile
Faster revenue growth than 76% of similar nonprofits.
Balance Sheet
Assets
Down$373,700
Down $69,009 (-16%) from 2020
Net Assets
Down$373,503
Down $66,399 (-15%) from 2020
Liabilities
Down$197
Down $2,610 (-93%) from 2020
Revenue And Expenses
Revenue
Up$66,103
Up $22,423 (+51%) from 2020
Expenses
Up$115,909
Up $69,633 (+150%) from 2020
Net Income
Down-$49,806
Down $47,210 (-1819%) from 2020
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2021 to Dec 31, 2021
- Signed
- Mar 31, 2022
- Return Version
- 2021v4.0
- Gross Receipts
- $66,103
Mission and Program Overview
Mission
The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. | - | $113,962 |
| PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM. | - | $1,947 |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| NICK COX PHD | Associate Di | - | $0 | - | - |
| ADRIENNE DAY PHD | Treasurer An | - | $0 | - | - |
| ROBERT HAGOPIAN | Director Busines | - | $0 | - | - |
| LUTZ JERMUTUS | Senior Direc | - | $0 | - | - |
| ADAM MEZO PHD | Sr. Director | - | $0 | - | - |
| RIE SCHULTZ HANSEN PHD | SVP & Chief | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Peptide Therapeutics Foundation
- EIN
- 26-3728931
- Phone
- 8586571511
- Address
- 9395 CABOT DRIVE, SAN DIEGO, CA 92126
Signing Officer
- Name
- Adrienne Day Phd
- Title
- Treasurer and Director
- Phone
- 8586571511
- Signed
- 2022-03-31
Preparer
- Firm
- GOODSELL & COMPANY INC CPA'S
- Address
- 2366 FRONT STREET, SAN DIEGO, CA 92101-1414
- Preparer
- Steven J Holc CPA
- Phone
- 6192384343
Supplemental Narrative
Additional Explanations
Form 990-ez, Part I, Line 16
“Expenses symposium expenses 89,548 foundation maintenance 23,129 total 112,677”
Form 990-ez, Part I, Line 20
“-16,593 unrealized loss on investments”
Form 990-ez, Part II, Line 26
“Accrued symposium expense 2,807 197”
Form 990-ez, Part III
“The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.”
Form 990-ez, Part III, Line 28
“Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 13 postdoctoral fellows and graduate students with free registration to the symposium.”
Form 990-ez, Part III, Line 31
“Peptide therapeutics has assets in an a brokerage firm. Expenses are related to the brokerage firm.”
Raw XML Appendix178 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | THE ORGANIZATION |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 8586571511 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 9395 CABOT DRIVE |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | SAN DIEGO |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92126 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 442709 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 373700 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 29980 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -49806 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 3232 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 442709 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 373700 |
| IRS990EZ/GainOrLossFromSaleOfAssetsAmt | 0 | 8944 |
| IRS990EZ/GrossReceiptsAmt | 0 | 66103 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InvestmentIncomeAmt | 0 | 6999 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 439902 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 373503 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 439902 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 373503 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | NICK COX PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | ADRIENNE DAY PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | ROBERT HAGOPIAN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | LUTZ JERMUTUS |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | ADAM MEZO PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | RIE SCHULTZ HANSEN PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | ASSOCIATE DI |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | TREASURER AN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | DIR. BUSINES |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | SENIOR DIREC |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | SR. DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | SVP & CHIEF |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | -16593 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 112677 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 20180 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 1 | PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 113962 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 1 | 1947 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SaleOfAssetsGrossAmt | 0 | 8944 |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 2807 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 197 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 115909 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 115909 |
| IRS990EZ/TotalRevenueAmt | 0 | 66103 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.PEPTIDETHERAPEUTICS.ORG |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | OTHER INCOME 3,492 |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | PART III, LINE 12 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 50160 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 43680 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 89945 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 89970 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 134940 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 408695 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt | 0 | 6999 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 6999 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 20180 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 6200 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 31320 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 35390 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt | 0 | 37634 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 130724 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt | 0 | 6999 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 6999 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.01000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 2618 |
| IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 874 |
| IRS990ScheduleA/OtherIncome509Grp/TotalAmt | 0 | 3492 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.98090 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.99430 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 539419 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 70340 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 49880 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 121265 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 125360 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 172574 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 539419 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 77339 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 49880 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 121265 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 127978 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 173448 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 549910 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES SYMPOSIUM EXPENSES 89,548 FOUNDATION MAINTENANCE 23,129 TOTAL 112,677 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | -16,593 UNREALIZED LOSS ON INVESTMENTS |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | ACCRUED SYMPOSIUM EXPENSE 2,807 197 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART I, LINE 20 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART II, LINE 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990-EZ, PART III, LINE 28 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990-EZ, PART III, LINE 31 |
| ReturnHeader/BuildTS | 0 | 2022-09-23 18:48:47Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | ADRIENNE DAY PHD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | TREASURER AND DIR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 8586571511 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2022-03-31 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | PEPTIDE THERAPEUTICS FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | PEPT |
| ReturnHeader/Filer/EIN | 0 | 263728931 |
| ReturnHeader/Filer/PhoneNum | 0 | 8586571511 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 9395 CABOT DRIVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92126 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 331005644 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | GOODSELL & COMPANY INC CPA'S |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 2366 FRONT STREET |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 921011414 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 6192384343 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2022-03-23 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | STEVEN J HOLC CPA |
| ReturnHeader/ReturnTs | 0 | 2022-10-05T13:09:35-04:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | ADRIENNE |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | DAY PHD |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2021-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2021-12-31 |
| ReturnHeader/TaxYr | 0 | 2021 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2021 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $373,700
- Liabilities
- $197
- Net assets
- $373,503
- Revenue
- $66,103
- Expenses
- $115,909
- Net income
- -$49,806